CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
8 research outputs found
Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review
Author
Aubagio
Denise A. Herriott
+22 more
DM Wingerchuk
G Giovannoni
Gilenya
Howard S. Friedman
John J. Ko
JT Phillips
K Treadaway
L Kappos
L Kappos
N Agashivala
N Bergvall
P O'Connor
Peri Barr
Prakash Navaratnam
R Gold
R Halpern
R Hupperts
Rahul Sasane
RJ Fox
S Cohn
Tara Nazareth
Tecfidera
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overview
Author
Agashivala N
Aubagio
+36 more
Beatriz Canibaño
Boulenouar Mesraoua
Cannella B
Comi G
di Nuzzo L
Dirk Deleu
EMA
EMA Gilenya
EMA recommendation
European Medicines Agency (EMA)
European Medicines Agency (EMA)
European Medicines Agency [Internet]
European Medicines Agency [Internet]
European Medicines Agency Committee for Medical Products for Human Use
Faiza Ibrahim
FDA Drug Safety Communication
Gayane Melikyan
Gilenya
Giovannoni G
Hassan Al Hail
Hassan Al Hussein
Havrdova E
Kappos L
Longbrake EE
Lubna El-Sheikh
Montalban X
Musab Ali
National Institutes of Health Clinicaltrials.com
Novartis Pharma GmbH
Osiri M
Tecfidera
US FDA
US FDA
US FDA. GILENYA (fingolimod)
Yolande Hanssens
Ziemssen T
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Neurological involvement and characterization in acquired hemophagocytic lymphohistiocytosis in adulthood
Author
Abellan
Abreu
+23 more
Brett J. Theeler
Carlo Tornatore
Decaminada
Deiva
European Medicines Agency
Faria S. Amjad
Filipovich
Gilenya
Gurgey
Haddad
Henter
Horne
Ishikura
Janka
Jason S. Hawley
Kidd
Ozgen
Sean M. Gratton
Sedrak
Shabbir
Tasha R. Powell
Tierney
Woo Goo
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Cardiovascular effects of fingolimod: Relevance, detection and approach
Author
Alewijnse
Brinkmann
+43 more
Brinkmann
Brinkmann
Chae
Chun
Chun
Cohen
Cohen
DiMarco
Egom
Foster
Fukushima
Gardell
Gilenya
Gold
Graler
Groves
Hartung
Hisano
Hughes
Im
Kappos
Khatri
Kovarik
Kovarik
Koyrakh
Liu
Mandala
Matloubian
Means
Mutoh
Noguchi
Oo
Peters
Rosen
Salomone
Schmouder
Schwab
Sefcik
Singer
Spiegel
Tolle
Waeber
Walsh
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Cardiovascular effects of fingolimod: Relevance, detection and approach
Author
Alewijnse
Brinkmann
+43 more
Brinkmann
Brinkmann
Chae
Chun
Chun
Cohen
Cohen
DiMarco
Egom
Foster
Fukushima
Gardell
Gilenya
Gold
Graler
Groves
Hartung
Hisano
Hughes
Im
Kappos
Khatri
Kovarik
Kovarik
Koyrakh
Liu
Mandala
Matloubian
Means
Mutoh
Noguchi
Oo
Peters
Rosen
Salomone
Schmouder
Schwab
Sefcik
Singer
Spiegel
Tolle
Waeber
Walsh
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
Author
A Garcia Merino
AJ García-Ruiz
+15 more
Consejo General de Colegios de Farmacéuticos
F Pan
G Kobelt
Gilenya® Summary of Products Characteristics
J Castelli-Haley
JD Prescott
JH Noseworthy
LJ Julian
M Chambers
O Fernández
O Fernández
P Trueman
R Sanchez-De la Rosa
S Otero-Romero
SM Szabo
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis
Author
Bartholomaus
Billich
+37 more
Brinkmann
Brinkmann
Chun
Cohen
Compston
Cox
Foster
GILENYA®
Group PPoRaDbIb-aSiMSS
Gräler
IFNB Multiple Sclerosis Study Group
Jacobs
Johnson
Kahan
Kappos
Kataoka
Kovarik
Kovarik
Kovarik
Kovarik
Kovarik
Kovarik
Kurtzke
Love
Mandala
Matloubian
Mohr
Nebert
O’Connor
Polman
Polman
Rio
Rudick
Sanna
Tremlett
TYSABRI®
Van Assche
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Immunomodulators
Author
Afridi
Agirgol
+109 more
Ahmed
Akkach
Almogairen
Alnahdi
Azizi
Baghbanian
Belatacept (Nujojix®)
Berktas
Breslin
Cakmak
Calafat
Campos
Canoval
Carubbi
Chadha
Chen
Choudhary
Chow
Ciurleo
Dimethyl fumarate (Tecfidera®)
Ding
Everolimus (Afinitor®)
Fan
Faustino
Filosto
Fingolimod (Gilenya®)
Fujii
Gao
Gardin
Gengraf (cyclosporine)
George
Glatiramer (Copoxane® Glatopa®)
Gulde
He
Heekin
Hessels
Jain
Jimenez
Joo
Kaushik
Kawabe
Kawai
Khanna
Khimani
Konishi
Kosloski
Kwok
Lai
Lao
Leflunomide (Arava®)
Leino
Levamisole (Ergamisol®)
Li
Liao
Ling
Liu
Lopez-Soler
Lotscher
Mahmoud Karrar
Mancini
Menezes
Minouni
Moadel
Moles-Poveda
Montastruc
Mycophenolic acid (Mycortic)
Negrotto
Neoral (cyclosporine)
Nguyen
Nure
Orencia® (abatacept)
Pakchotanon
Plana-Pla
Prograf (tacrolimus)
Protopic (tacrolimus) 0.03% 0.1% ointments
Quintanilla-Bordas
Rastas
Restasis (cyclosporine)
Sabater-Abad
Sainz de la Maza
Sandimmune (cyclosporine)
Sari
Schaeffeler
Shao
Sharma
Sharma
Sierra Morales
Sikavi
Simon
Sinnecker
Siponimod (Mayzent®)
Sirolimus (Rapamune®)
Smeralda
Spasic
Spiegel
Streight
Tanimura
Teriflunomide (Aubagio®)
Terto
Tsunematsu
Uno
Uno
van Gennep
Villedon de Naide
Walker
Watanabe
Wiemer-Kruel
Xu
Zhai
Publication venue
'Elsevier BV'
Publication date
01/01/2020
Field of study
No full text
Crossref
The Touro College and University System